Specific code 2015 ICD-9-CM Diagnosis Code E942.2
Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM E942.2 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, E942.2 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
  • E942.2 describes the circumstance causing an injury, not the nature of the injury.
  • No ICD-10-CM code(s) convert to ICD-9-CM E942.2
Approximate Synonyms
  • 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction (disorder)
  • Adverse effect of antihyperlipidemic
  • Adverse effect of antihyperlipidemic drug
  • Adverse effect of bile acid resin
  • Adverse effect of fibric acid derivative
  • Adverse effect of niacin
  • Adverse effect of statin
  • Adverse reaction to fibric acid derivative
  • Adverse reaction to statin
  • Bile acid resin adverse reaction
  • HMG COA reductase inhibitor adverse reaction
  • Lipid-lowering drug adverse reaction
  • Nicotinic acid adverse reaction
E942.2 Excludes
Applies To
  • Cholestyramine
  • Clofibrate
  • Nicotinic acid derivatives
  • Sitosterols
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM E942.2 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.